Abstract
Preeclampsia remains a formidable disease in the second half of pregnancy. Therefore, the search for new drugs for the treatment and prevention of preeclampsia is an urgent task of modern pharmacology. Materials and methods. The experiment was performed on female Wistar rats. The studied drugs were administered from 10 to 21 days of pregnancy. Functional tests were performed on the 21st day of pregnancy. Results. The use of a peptide that imitates erythropoietin а-helix B in experimental preeclampsia leads to a pronounced correction of pathological changes: blood pressure decreased, microcirculation in the placenta increased, and the morphological picture in the placenta improved. Resume. The results indicate the promise of the use of a peptide imitating а-helix B erythropoietin in experimental preeclampsia.
Highlights
Preeclampsia remains a formidable disease in the second half of pregnancy
The search for new drugs for the treatment and prevention of preeclampsia is an urgent task of modern pharmacology
The experiment was performed on female Wistar rats
Summary
Preeclampsia remains a formidable disease in the second half of pregnancy. the search for new drugs for the treatment and prevention of preeclampsia is an urgent task of modern pharmacology. The use of a peptide that imitates erythropoietin α-helix B in experimental preeclampsia leads to a pronounced correction of pathological changes: blood pressure decreased, microcirculation in the placenta increased, and the morphological picture in the placenta improved. The results indicate the promise of the use of a peptide imitating α-helix B erythropoietin in experimental preeclampsia.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
